摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-phenylcyclohex-2-ene-1-carboxylic acid | 24102-01-0

中文名称
——
中文别名
——
英文名称
2-phenylcyclohex-2-ene-1-carboxylic acid
英文别名
2-phenylcyclohex-2-enecarboxylic acid;2-Phenyl-cyclohexen-3-carbonsaeure;2-Phenylcyclohex-2-en-carbonsaeure;2-Phenyl-2-cyclohexencarbonsaeure
2-phenylcyclohex-2-ene-1-carboxylic acid化学式
CAS
24102-01-0
化学式
C13H14O2
mdl
——
分子量
202.253
InChiKey
FPXFKRJXSSAIMJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    76-80 °C(Solv: ligroine (8032-32-4))
  • 沸点:
    364.6±42.0 °C(Predicted)
  • 密度:
    1.161±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    摘要:
    Purpose. To design and evaluate a new class of soft anticholinergics with subtype selectivity.Methods. A new class of soft anticholinergics was designed based on the "inactive metabolite" approach. Four compounds were synthesized. The potency and soft nature of the compounds were evaluated by receptor binding, cardiac, and mydriatic studies. Stability and pharmacokinetic studies were also performed on these newly synthesized soft anticholinergics.Results. Receptor binding studies of the soft anticholinergics on cloned muscarinic receptors indicated pKi values in the range of 7.5 to 8.9. Two compounds, 9a and 13a, of the series showed muscarinic subtype receptor selectivity (M-3/M-2). In mydriatic studies, 13a and 13b showed shorter duration of action in the treated eyes than tropicamide. In the control eyes, significant dilation of pupils was found only in rabbits treated with atropine and tropicamide, indicating that the soft anticholinergics lack systemic effects because of their facile hydrolytic deactivation. Consistent with their soft nature, this new class of soft anticholinergics displayed much shorter cardiovascular effects in the carbachol-induced bradycardia (10 to 15 min) in rats than atropine (>60 min). Stability and pharmacokinetic studies suggested that the new soft anticholinergics were rapidly eliminated from plasma (systemic circulation) after i.v. administration.Conclusions. A new class of anticholinergics was designed and synthesized, and the PK/PD evaluation confirmed they were potent "soft" anticholinergics; two of them showed muscarinic receptor subtype selectivity (M-3/M-2).
    DOI:
    10.1023/a:1026160023030
  • 作为产物:
    参考文献:
    名称:
    摘要:
    Purpose. To design and evaluate a new class of soft anticholinergics with subtype selectivity.Methods. A new class of soft anticholinergics was designed based on the "inactive metabolite" approach. Four compounds were synthesized. The potency and soft nature of the compounds were evaluated by receptor binding, cardiac, and mydriatic studies. Stability and pharmacokinetic studies were also performed on these newly synthesized soft anticholinergics.Results. Receptor binding studies of the soft anticholinergics on cloned muscarinic receptors indicated pKi values in the range of 7.5 to 8.9. Two compounds, 9a and 13a, of the series showed muscarinic subtype receptor selectivity (M-3/M-2). In mydriatic studies, 13a and 13b showed shorter duration of action in the treated eyes than tropicamide. In the control eyes, significant dilation of pupils was found only in rabbits treated with atropine and tropicamide, indicating that the soft anticholinergics lack systemic effects because of their facile hydrolytic deactivation. Consistent with their soft nature, this new class of soft anticholinergics displayed much shorter cardiovascular effects in the carbachol-induced bradycardia (10 to 15 min) in rats than atropine (>60 min). Stability and pharmacokinetic studies suggested that the new soft anticholinergics were rapidly eliminated from plasma (systemic circulation) after i.v. administration.Conclusions. A new class of anticholinergics was designed and synthesized, and the PK/PD evaluation confirmed they were potent "soft" anticholinergics; two of them showed muscarinic receptor subtype selectivity (M-3/M-2).
    DOI:
    10.1023/a:1026160023030
点击查看最新优质反应信息

文献信息

  • EtAlCl<sub>2</sub>/2,6-Disubstituted Pyridine-Mediated Carboxylation of Alkenes with Carbon Dioxide
    作者:Shinya Tanaka、Kota Watanabe、Yuuki Tanaka、Tetsutaro Hattori
    DOI:10.1021/acs.orglett.6b00918
    日期:2016.6.3
    and trialkyl-substituted alkenes undergo carboxylation with CO2 in the presence of EtAlCl2 and 2,6-dibromopyridine to afford the corresponding α,β- and/or β,γ-unsaturated carboxylic acids. This reaction is suggested to proceed via the electrophilic substitution of EtAlCl2 with the aid of the base, followed by the carbonation of the resulting ate complex. This reaction can be applied to terminal dialkylalkenes
    在EtAlCl 2和2,6-二溴吡啶的存在下,α-芳基烯烃和三烷基取代的烯烃与CO 2进行羧化反应,得到相应的α,β-和/或β,γ-不饱和羧酸。建议该反应通过在碱的辅助下对EtAlCl 2进行亲电取代,然后将所得的盐配合物碳酸化来进行。通过使用2,6-二叔丁基吡啶和2,6-二溴吡啶的混合物,该反应可用于末端二烷基烯烃。
  • [EN] METHODS FOR MAKING CYCLOHEXENE OXIDE-CONTAINING ESTERS<br/>[FR] PROCÉDÉS DE FABRICATION D'ESTERS CONTENANT DE L'OXYDE DE CYCLOHEXÈNE
    申请人:ARKEMA INC
    公开号:WO2018231804A1
    公开(公告)日:2018-12-20
    A method of making an ester comprised of at least one cyclohexene oxide moiety is provided, involving the steps of a) esterifying an alcohol with a carboxylic acid-substituted cyclohexene to obtain an intermediate comprised of at least one carboxylate-substituted cyclohexene moiety; and b) epoxidizing the intermediate obtained in step a) with an epoxidizing agent to obtain the ester comprised of at least one cyclohexene oxide moiety. The esters have utility as acid scavengers, plasticizers and reactive resins.
    提供一种制备至少含有一个环己烯氧化物基团的酯的方法,包括以下步骤:a)用具有羧基取代环己烯的羧酸酯化醇,以获得至少含有一个羧酸酯基团的环己烯中间体;b)用环氧化剂环氧化步骤a)中获得的中间体,以获得至少含有一个环己烯氧化物基团的酯。这些酯具有作为酸中和剂、增塑剂和反应性树脂的用途。
  • Esters of N-alkyl-nortropines and their quaternary derivatives having anti-bronchospastic activity, process for their preparation and pharmaceutical compositions containing them
    申请人:Laboratori Guidotti S.p.A.
    公开号:EP0234400A1
    公开(公告)日:1987-09-02
    The esters of N-alkyl-nortropines with phenyl-cyclohexen-carboxylic and phenyl-cyclohexen-acetic acids and their quaternary ammonium derivatives with alkyl halides and alkyl sulphates having general formula: wherein when and when whereas R'= -, -H, -CH3, -CH2-CH3, -CH2-CH2-CH3, -CH(CH3)2, -CH2-CH2-CH2-CH3, -CH2-CH-(CH3)2 X- = Cl, Br, J, CH3S04 show anti-bronchospastic activity. The invention relates also to the processes for their preparation and to the pharmaceutical compositions containing them.
    N-烷基去甲托品与苯基-环己烯-羧酸和苯基-环己烯-乙酸的酯及其与烷基卤化物和烷基硫酸盐的季铵盐衍生物,其通式为 其中 当 和 而 R'= -、-H、-CH3、-CH2-CH3、-CH2-CH2-CH3、-CH(CH3)2、-CH2-CH2-CH2-CH3、-CH2-CH-(CH3)2 X- = Cl、Br、J、CH3S04 显示抗支气管痉挛活性。 本发明还涉及它们的制备工艺和含有它们的药物组合物。
  • Catalytic photocarboxylation of 1,1-diphenylethylene with N,N,N′,N′-tetramethylbenzidine and carbon dioxide
    作者:Yoshikatsu Ito
    DOI:10.1016/j.tet.2007.02.013
    日期:2007.4
    Photocarboxylation of 1,1 -diphenylethylene with N,N,N',N',-tetramethylbenzidine (TMB) in MeCN under bubbling Of CO2 proceeded with high catalytic efficiency, giving 3,3-diphenylacrylic acid (DPA) and 3-hydroxy-3,3-diphenylpropionic acid (20). The turnover number (TON=(DPA+20)/TMB) reached 17. Similarly, 1-phenyl-1-cyclohexene yielded cis-2-acetamido-2-phenylcyclohexanecarboxylic acid with TON 5.9. As compared with related N,N-dimethylaniline derivatives, TMB is more resistant to photodecomposition, has the much larger absorbance in the S-0 -> S-1 transition, and has the lower quenching efficiency by CO2. Probably these factors are partly responsible for the high TON observed for TMB. (c) 2007 Elsevier Ltd. All rights reserved.
  • METHODS FOR MAKING CYCLOHEXENE OXIDE-CONTAINING ESTERS
    申请人:Arkema Inc.
    公开号:US20200165218A1
    公开(公告)日:2020-05-28
    A method of making an ester comprised of at least one cyclohexene oxide moiety is provided, involving the steps of a) esterifying an alcohol with a carboxylic acid-substituted cyclohexene to obtain an intermediate comprised of at least one carboxylate-substituted cyclohexene moiety; and b) epoxidizing the intermediate obtained in step a) with an epoxidizing agent to obtain the ester comprised of at least one cyclohexene oxide moiety. The esters have utility as acid scavengers, plasticizers and reactive resins.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐